University of Pennsylvania’s Abramson Cancer Center

Penn’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Its preeminent position is reflected in their continuous designation as a Comprehensive Cancer Center by the National Cancer Institute since 1973, one of 41 such Centers in the United States. The clinical program, comprised of a dedicated staff of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists, and patent care coordinators, currently sees over 90,000 outpatient visits, over 11,800 inpatient discharges, and provides over 37,000 chemotherapy treatments, and more than 66,000 radiation treatments. In addition, the Abramson Cancer Center is home to the 400+ basic, translational, and clinical scientists who work relentlessly to determine the pathogenesis of cancer.

MD Anderson Cancer Center at Cooper

Through our collaboration with the Wistar Institute, doctors from the MD Anderson Cancer Center at Cooper are participating in Anixa's cancer biomarker study. The MD Anderson Cooper facility offers expanded programs and services in an environment that fosters a team approach to medicine. Cancer specialists from various medical disciplines conduct concurrent, complementary clinical sessions with patients, fostering professional interaction and collaboration. Patients benefit from easy access to advanced treatment technologies and a full range of supportive care services.

The Wistar Institute Cancer Center

Founded in 1892 as the nation’s first independent biomedical research institute and located on the campus of the University of Pennsylvania, Wistar is an international leader in the biomedical research fields of cancer, immunology and infectious diseases, a National Cancer Institute (NCI)-designated Cancer Center, and part of the NCI’s select network of national cancer research centers, holding an ‘Exceptional’ rating — the highest possible ranking awarded.

Penn Medicine Virtua Cancer Program

The Penn Medicine Virtua Cancer Program is accredited by both the American College of Surgeons (ACos) and by the National Accreditation Program for Breast Centers. As one of 74 nationally accredited cancer programs to be awarded the Commission on Cancer by the ACoS, Virtua raises the bar on quality cancer care and increases awareness about quality choices among patients with cancer, as well as their loved ones. Virtua provides a full range of clinical oncology social work services to meet the psychological needs of cancer patients and their families.

New Jersey Urology

New Jersey Urology (NJU) is the largest urology practice in the country. As a result, NJU is able to offer patients access to all urological treatments close to home. NJU proudly serves the state of New Jersey with nearly 100 physicians practicing at more than 45 convenient locations, including four state-of-the-art Cancer Treatment Centers. Utilizing the latest technology and techniques in the industry, NJU offers advanced urologic care with a personal touch. The health of NJU’s patients is of utmost importance.

Anixa is working with the following U.S. Department of Veterans Affairs VA Medical Centers and their research affiliates under Clinical Trial Cooperative Research and Development Agreements:

Richmond VA Medical Center and McGuire Research Institute, Inc.

VA Maryland Health Care System and Baltimore Research and Education Foundation, Inc.

VA North Texas Health Care System-Dallas Medical Center and Dallas VA Research Corporation

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study


Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology


Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study


Cancer Fact: Lung cancer accounts for 13% of worldwide cancer incidences.